Home » Novartis Sells US Rights to Enablex for $400 Million
Novartis Sells US Rights to Enablex for $400 Million
Novartis agreed to sell the U.S. rights to bladder medicine Enablex for $400 million.
DailyFinance
DailyFinance
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May